Replay available

Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call

Milestone Scientific Inc. (NYSE: MLSS) Q1 2026 earnings conference call, held 2026-05-14. Replay captured from the company's public earnings webcast.

Thu, May 14, 2026 at 8:30 AMendedReplay
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

James Carbonara

Investor Relations (Hayden IR)

Eric Hines

Chief Executive Officer

Anthony Vendetti

Analyst, Maxim Group

Bruce Jackson

Analyst, StoneX

John Korb

Analyst

Gary Carroll

Analyst

Replay transcript excerpt

Hi, everyone. Welcome to the Milestone Scientific, Inc. First Quarter 2026 Financial Results and Business Update Conference Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, James Carbonara from Hayden IR. The floor is yours. Thank you, Operator. Before we begin, please note that today's call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Please refer to our earnings specialties as well as our filings with the SEC, including our 2025 Form 10-K for discussion of these risks. A replay of this call will be available shortly after its conclusion. With that, I'll turn the call over to our CEO, Eric Hines. Thank you, James, and good morning, everybody, and thank you for doing our call today. I especially want to thank everybody who participated in our pipe in April and your continued support for Milestone. It is greatly appreciated. Our first quarter results reflect continued progress as we execute on the foundation we established in 2025. We remain focused on building a disciplined operating model. We're spending as aligned with revenue generation. and Clear Return on Investment. That focus is reflected in our results. We maintained a relatively stable revenue base in the quarter, despite the inability to ship certain booked orders to the Middle East due to the ongoing global conflict in the region. Even with that headwind, we reduced operating expenses by approximately $1.3 million, or more than 30% year over year, ...

More from Milestone Scientific, Inc.